Standing Vaccination Commission publishes new vaccination recommendations

The Standing Vaccination Commission at the Robert Koch Institute has published its current vaccination recommendations. There are changes in the vaccine schedule for pneumococcal vaccination in infancy and early childhood, meningococcal B vaccine, yellow fever vaccine and passive immunization against chickenpox.
In addition, the STIKO has editorially revised the measles vaccination recommendations.

Image: Ilike - fotolia

In the pneumococcal vaccine, infants will in future receive three instead of the previous four vaccine doses of a pneumococcal conjugate vaccine, at the age of 2, 4 and 11-14 months (so-called 2 + 1 vaccination schedule, two primary immunizations plus one refresher). , For premature babies (birth before the completed 37th week of pregnancy), the 3 + 1 scheme is still recommended, they should continue to receive four vaccine doses at the age of 2, 3, 4 and 11-14 months.

Although a vaccine has been available in Germany since December 2013 for serogroup B meningococci. The STIKO considers the study results to date and the resulting evidence not sufficient for a decision on a general vaccine recommendation. However, in the future, the STIKO recommends vaccination against meningococcal B (indi cation vaccination) for per- nons with specific underlying diseases. When it comes to yellow fever vaccination, the STIKO does not recommend freshening up.
More information can be found here. (Pm)